Ellington Residential Mortgage REIT (EARN)
(Real Time Quote from BATS)
$6.74 USD
+0.07 (1.05%)
Updated Apr 23, 2024 03:46 PM ET
2-Buy of 5 2
D Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Ellington Residential Mortgage REIT falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 43 | 35 | 28 | 27 | 44 |
Cost Of Goods | 2 | 2 | 3 | 3 | 3 |
Gross Profit | 40 | 33 | 26 | 25 | 41 |
Selling & Adminstrative & Depr. & Amort Expenses | 49 | 18 | 6 | 13 | 38 |
Income After Depreciation & Amortization | -8 | 15 | 20 | 12 | 3 |
Non-Operating Income | 13 | -45 | -26 | 9 | 19 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 5 | -30 | -6 | 20 | 22 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 5 | -30 | -6 | 20 | 22 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 5 | -30 | -6 | 20 | 22 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -7 | 17 | 27 | 26 | 18 |
Depreciation & Amortization (Cash Flow) | 1 | 2 | 8 | 14 | 15 |
Income After Depreciation & Amortization | -8 | 15 | 20 | 12 | 3 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 14.88 | 13.16 | 12.68 | 12.35 | 12.46 |
Diluted EPS Before Non-Recurring Items | 0.86 | 1.06 | 1.27 | 1.26 | 0.91 |
Diluted Net EPS (GAAP) | 0.31 | -2.29 | -0.50 | 1.63 | 1.79 |
Fiscal Year end for Ellington Residential Mortgage REIT falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 11.89 | 11.25 | 10.07 | 9.34 |
Cost Of Goods | NA | 0.61 | 0.52 | 0.53 | 0.53 |
Gross Profit | NA | 11.28 | 10.74 | 9.54 | 8.81 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 12.28 | 13.19 | 12.65 | 10.48 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1.00 | -2.45 | -3.11 | -1.67 |
Non-Operating Income | NA | 13.44 | -8.97 | 4.32 | 4.01 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 12.44 | -11.42 | 1.20 | 2.34 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 12.44 | -11.42 | 1.20 | 2.34 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 12.44 | -11.42 | 1.20 | 2.34 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 16.66 | 15.20 | 13.94 | 13.67 |
Diluted EPS Before Non-Recurring Items | NA | 0.27 | 0.21 | 0.17 | 0.21 |
Diluted Net EPS (GAAP) | NA | 0.80 | -0.75 | 0.09 | 0.17 |